← Back to Search

Regenerative Medicine

Fetoscopic Repair for Spina Bifida

N/A
Waitlist Available
Led By Rodrigo Ruano, MD, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Singleton pregnancy
MMC diagnosis with the upper boundary located between Thoracic 1 (T1) and Sacral 1 (S1)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial is testing a new, less invasive way to fix spina bifida in pregnancy. They want to see if it's just as effective as the current method, but with less risk to the mother.

Eligible Conditions
  • Spina Bifida
  • Neural Tube Defects

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are pregnant with only one baby.
Select...
You have a diagnosis of a type of cancer called medulloblastoma and the upper part of the cancer is between the first thoracic vertebra and the first sacral vertebra.
Select...
You have a specific type of brain abnormality called Arnold-Chiari type II malformation, confirmed by MRI.
Select...
You do not have any abnormal chromosomes or related health issues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Maternal adverse events
Neonatal adverse events

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pregnant women diagnosed with fetal myelomeningoceleExperimental Treatment1 Intervention
Women subjects who are pregnant and diagnosed with myelomeningocele (MMC), also known as fetal spina bifida or neural tube defect, will undergo a minimally invasive fetoscopic repair of MMC.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,176 Previous Clinical Trials
3,758,048 Total Patients Enrolled
1 Trials studying Spina Bifida
60 Patients Enrolled for Spina Bifida
Rodrigo Ruano, MD, PhDPrincipal InvestigatorMayo Clinic
4 Previous Clinical Trials
111 Total Patients Enrolled

Media Library

Minimally Invasive Fetoscopic Regenerative Repair (Regenerative Medicine) Clinical Trial Eligibility Overview. Trial Name: NCT03936322 — N/A
Spina Bifida Research Study Groups: Pregnant women diagnosed with fetal myelomeningocele
Spina Bifida Clinical Trial 2023: Minimally Invasive Fetoscopic Regenerative Repair Highlights & Side Effects. Trial Name: NCT03936322 — N/A
Minimally Invasive Fetoscopic Regenerative Repair (Regenerative Medicine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03936322 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this trial still being welcomed?

"According to the information posted on clinicaltrials.gov, presently this medical trial is not actively recruiting patients. The date of its initial posting was May 7th 2019 and it was last updated January 25th 2021. Nevertheless, there are 30 other studies that are currently taking part in participant recruitment at this time."

Answered by AI
~1 spots leftby Mar 2025